Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Dec;20(6):839–840. doi: 10.1128/aac.20.6.839

Dose-Ranging Study of Ceftriaxone for Uncomplicated Gonorrhea in Men

H Hunter Handsfield 1,2,4, Victory L Murphy 2, King K Holmes 3,4
PMCID: PMC181809  PMID: 6275788

Abstract

Uncomplicated gonorrhea in men was successfully treated with ceftriaxone in single intramuscular doses of 125 mg (15 patients), 250 mg (16 patients), or 500 mg (15 patients). All 45 pretreatment gonococcal isolates tested were inhibited by ≤0.016 μg of ceftriaxone per ml. Treatment was well tolerated and caused no toxicity.

Full text

PDF
839

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Catlin B. W. Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampicillin resistance. Antimicrob Agents Chemother. 1975 Mar;7(3):265–270. doi: 10.1128/aac.7.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Eickhoff T. C., Ehret J. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative. Antimicrob Agents Chemother. 1981 Mar;19(3):435–442. doi: 10.1128/aac.19.3.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Neu H. C., Meropol N. J., Fu K. P. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother. 1981 Mar;19(3):414–423. doi: 10.1128/aac.19.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ng W. S., Chau P. Y., Arnold K. In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics. Antimicrob Agents Chemother. 1981 May;19(5):925–926. doi: 10.1128/aac.19.5.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Perine P. L., Morton R. S., Piot P., Siegel M. S., Antal G. M. Epidemiology and treatment of penicillinase-producing Neisseria gonorrhoeae. Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):152–158. doi: 10.1097/00007435-197904000-00021. [DOI] [PubMed] [Google Scholar]
  6. Seddon M., Wise R., Gillett A. P., Livingston R. Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1980 Aug;18(2):240–242. doi: 10.1128/aac.18.2.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Shannon K., King A., Warren C., Phillips I. In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases. Antimicrob Agents Chemother. 1980 Aug;18(2):292–298. doi: 10.1128/aac.18.2.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wiesner P. J., Holmes K. K., Sparling P. F., Maness M. J., Bear D. M., Gutman L. T., Karney W. W. Single doses of methacycline and doxycycline for gonorrhea: a cooperative study of the frequency and cause of treatment failure. J Infect Dis. 1973 Apr;127(4):461–466. doi: 10.1093/infdis/127.4.461. [DOI] [PubMed] [Google Scholar]
  9. Yoshikawa T. T., Shibata S. A., Herbert P., Oill P. A. In vitro activity of Ro 13-9904, cefuroxime, cefoxitin, and ampicillin against Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1980 Aug;18(2):355–356. doi: 10.1128/aac.18.2.355. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES